ERNA
NASDAQ
$5.43
Ernexa Therapeutics Inc (ERNA)
Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients. The company is headquartered in Brooklyn, New York.
Sector:
Healthcare
Industry:
Biotechnology
Target: $30 (+452.49%)
Market Cap
$7.85M
Free Cash Flow Yield
-92.45%
Price Chart
Valuation
Market Cap$7.85M
P/S1275.37
P/B1.03
Profitability
Total Revenue (TTM)$83K
Gross Profit (TTM)$1K
EBITDA-$12M
EPS-$23.95
Financial Health
Free Cash Flow Yield-92.45%
Growth & Risk
Revenue 5Y CAGR-52.43%
FCF 5Y CAGR+3.39%
Sharpe Ratio-0.76